Scribd
Upload
25 views4 pages

DR Reddys Laboratories LTD Industry:Pharmaceuticals - Indian - Bulk Drugs & Formln LRG

- The document is a consolidated profit and loss statement for Dr. Reddy's Laboratories Ltd for the years March 2009 to March 2013. - It shows the company's total income increased from Rs. 7,107.70 crores in 2010 to Rs. 12,214 crores in 2013, with sales turnover rising from Rs. 7,062.60 crores to Rs. 11,967.40 crores over the same period. - Net profit increased from Rs. 351.5 crores in 2010 to Rs. 1,526.80 crores in 2013, while earnings per share before minority interest rose from Rs. 18.95 to Rs. 87.37 over the period reported.

Uploaded by

Santanu Das
Copyright
© Attribution Non-Commercial (BY-NC)
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as XLSX, PDF, TXT or read online on Scribd
25 views4 pages

DR Reddys Laboratories LTD Industry:Pharmaceuticals - Indian - Bulk Drugs & Formln LRG

- The document is a consolidated profit and loss statement for Dr. Reddy's Laboratories Ltd for the years March 2009 to March 2013. - It shows the company's total income increased from Rs. 7,107.70 crores in 2010 to Rs. 12,214 crores in 2013, with sales turnover rising from Rs. 7,062.60 crores to Rs. 11,967.40 crores over the same period. - Net profit increased from Rs. 351.5 crores in 2010 to Rs. 1,526.80 crores in 2013, while earnings per share before minority interest rose from Rs. 18.95 to Rs. 87.37 over the period reported.

Uploaded by

Santanu Das
Copyright
© Attribution Non-Commercial (BY-NC)
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as XLSX, PDF, TXT or read online on Scribd
You are on page 1/ 4

Company >> Finance >> P & L Consolidated

Dr Reddys Laboratories Ltd


Industry :Pharmaceuticals - Indian - Bulk
Drugs & Formln Lrg
(Rs in Crs)
Mar 13(12) Mar 12(12) Mar 11(12) Mar 10(12)
Year
INCOME :
11,967.40
9,855.00
7,532.50
7,062.60
Sales Turnover
71.8
40.5
97.3
31.6
Excise Duty
11,895.60
9,814.50
7,435.20
7,031.00
Net Sales
149.9
132.3
52.3
101.4
Other Income
168.5
152.6
164.5
-24.7
Stock Adjustments
Total Income
12,214.00 10,099.40
7,652.00
7,107.70
EXPENDITURE :
3,622.30
2,667.50
2,193.90
2,037.00
Raw Materials
335.4
225.9
183.3
141.5
Power & Fuel Cost
1,928.70
1,591.20
1,278.00
1,163.40
Employee Cost
712.8
695.2
478.2
591.1
Other Manufacturing Expenses
2,560.60
2,138.40
1,731.60
1,477.60
Selling and Administration Expenses
230.9
344.6
173.8
627.2
Miscellaneous Expenses
0
0
0
0
Less: Pre-operative Expenses Capitalised
9,390.70
7,662.80
6,038.80
6,037.80
Total Expenditure
2,823.30
2,436.60
1,613.20
1,069.90
Operating Profit
108.4
114.1
32.3
38.5
Interest
2,714.90
2,322.50
1,580.90
1,031.40
Gross Profit
550.2
518.1
398.1
413.1
Depreciation
0
0
0
0
Minority Interest (before tax)
2,164.70
1,804.40
1,182.80
618.3
Profit Before Tax
657
524.8
210.6
325.2
Tax
0
0
0
-2.4
Fringe Benefit Tax
-19.1
-21.3
-26.7
-56
Deferred Tax
1,526.80
1,300.90
998.9
351.5
Net Profit
0
0
0
0
Minority Interest (after tax)
0
0
0
0
Profit/Loss of Associate Company
1,300.90
998.9
351.5
Net Profit after Minority Interest & P/L Asso.Co. 1,526.80
-25.35
-91.13
19.55
-218.39
Extraordinary Items
1,552.15
1,392.03
979.35
569.89
Adjusted Net Profit
0
0
0
-32.6
Adjst. below Net Profit
1,657.70
807.3
116.2
103.6
P & L Balance brought forward
0
0
0
0
Statutory Appropriations
509.4
450.5
307.8
306.3
Appropriations
2,675.10
1,657.70
807.3
116.2
P & L Balance carried down
254.8
233.1
190.4
190
Dividend

Preference Dividend
Equity Dividend (%)
EPS before Minority Interest (Unit Curr.)
EPS before Minority Interest (Adj) (Unit Curr.)
EPS after Minority Interest (Unit Curr.)
EPS after Minority Interest (Adj) (Unit Curr.)
Book Value (Unit Curr.)
http://www.capitaline.com

0
300
87.37
0
87.37
0
375.09

0
275
74.48

0
225
57.21

0
225
18.95

74.48

57.21

18.95

294.16

238.29

223.74

Mar 09(12)
6,942.80
80.9
6,861.90
99.4
134.1
7,095.40
2,035.80
122.7
971.6
706
1,515.20
1,794.60
0
7,145.90
-50.5
108.2
-158.7
497.7
0
-656.4
272.4
11.3
-22.9
-917.2
0
0
-917.2
-1,180.30
263.1
0
1,200.10
0
179.3
103.6
105.3

0
125
0
0
209.39

You might also like